Buphenine

Buphenine
Clinical data

Trade names	Arlidin
Other names	Nylidrin
AHFS/Drugs.com	International Drug Names
ATC code	C04AA02 (WHO) G02CA02 (WHO)
Identifiers
IUPAC name 4-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]propyl}phenol
CAS Number	447-41-6
PubChem CID	4567
ChemSpider	4407
UNII	695DKH33EI
ChEMBL	ChEMBL114655^Y
CompTox Dashboard (EPA)	DTXSID4023387
ECHA InfoCard	100.006.531
Chemical and physical data
Formula	C₁₉H₂₅NO₂
Molar mass	299.414 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES OC(c1ccc(O)cc1)C(NC(C)CCc2ccccc2)C

Buphenine, also known as nylidrin and sold under the brand name Arlidin, is a β₂ adrenoreceptor agonist^[1] that acts as a vasodilator.^[2]

It was developed as a chemical derivative of oxilofrine, and first reported in the literature in 1950.^[3]

References

Mittag TW, Tormay A, Messenger M, Podos SM (February 1985). "Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin". Invest Ophthalmol Vis Sci. 26 (2): 163–9. PMID 2857689.{{cite journal}}: CS1 maint: deprecated archival service (link)
Freedman L (1955). "Arlidin: a new vasodilative sympathomimetic drug". Angiology. 6 (1): 52–8. doi:10.1177/000331975500600106. PMID 14350296. S2CID 46317963.
Külz F, Schneider M (1950). "Über neue gefäßerweiternde Sympathomimetika" [On new vasodilative sympathomimetics]. Klin Wochenschr (in German). 28 (31–32): 535–7. doi:10.1007/BF01481535. PMID 14775050.